Indeed, a large-scale study of 2,810 lymph node-negative breast cancer patients revealed that patients with a high or moderate expression level of Cathepsin-D in a primary tumor have a poor prognosis , independent of histologic grade, hormone receptor status, or tumor size[17]. This evidence concerns the gene CTSD and neoplasm.